4//SEC Filing
Gentry Leesa 4
Accession 0001641172-25-005108
CIK 0001574094other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:18 PM ET
Size
5.9 KB
Accession
0001641172-25-005108
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Gentry Leesa
Chief Clinical Officer
Transactions
- Award
Stock Option
2025-04-14+26,477→ 26,477 totalExercise: $0.84→ Common Stock (26,477 underlying)
Footnotes (1)
- [F1]On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035.
Documents
Issuer
RenovoRx, Inc.
CIK 0001574094
Entity typeother
Related Parties
1- filerCIK 0002013097
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 5:18 PM ET
- Size
- 5.9 KB